EventsThe 3rd International Electronic Conference on Metabolomics
Published
This submission belongs to the session D. Microbiota and Metabolomics of the event The 3rd International Electronic Conference on Metabolomics
Published date
15 Nov, 2018
Citation
Nicholas Rattray, Yuping Cai, Sajid Khan, Caroline Johnson, Yawei Zhang, [KEYNOTE] Identifying sex differences in colon cancer metabolism (Video), in Proceedings of The 3rd International Electronic Conference on Metabolomics, 15 November–30 November 2018, MDPI: Basel, Switzerland, doi: 10.3390/iecm-3-05847
Share
Email
Facebook
Twitter
LinkedIn

[KEYNOTE] Identifying sex differences in colon cancer metabolism (Video)

Nicholas Rattray 1,2
image
1. University of Strathclyde
2. Yale School of Public Health
3. Yale School of Medicine
Abstract

Colon cancer is the second most common cancer to affect women worldwide. While women have a 30-40% lower incidence of colon cancer than men, they have a higher likelihood of cancer presentation on the right-side of the colon. This is of high concern because patients with right-sided colon cancer have poorer clinical outcomes than those with left-sided colon cancers. The reasons for this difference in outcome are not known, however, it has been proposed that female hormones influence colonic metabolism, microbiome and affect tumor growth in this region of the colon. We have initially examined the metabolic differences between 210 colon tumor tissues from men and women with left and right-sided colon cancer using untargeted liquid chromatography mass spectrometry-based metabolomics. We show region- and sex-specific differences in tumor tissue metabolism that may influence tumor aggressiveness and patient outcomes.

Video from the Keynote Speaker Dr. Caroline H. Johnson can be found as below:

Keywords
colon cancer
sex-specific metabolism
Poster
IECM-3_CarolineJohnson_final.pdf
Metabolomic analysis revealed that green tea polyphenols decreased the formation of microbial metabolites of aromatic amino acids in humans
[KEYNOTE] Defining complex drug mechanisms with metabolomics (Video)